Stuart Apfel
Präsident bei Parallax Clinical Research LLC
Profil
Stuart Apfel has been Chief Medical Officer of Elite Pharmaceuticals, Inc. since January 2008 and Chief Scientific Officer since April 2008.
He founded Parallax Clinical Research LLC and serves as President.
Dr. Apfel served as a Consultant to Elite from January 2007 to December 2007, Director-Clinical Research and then Senior Director-Clinical Research of DOV Pharmaceuticals, Inc. from 2004 to 2006 and Associate Director-Clinical Research and then Director-Clinical Research of Purdue Pharma LP from 2000 to 2004.
Currently, he serves as Associate Professor of Neurology at the Albert Einstein College of Medicine and at Downstate Medical School.
Aktive Positionen von Stuart Apfel
| Unternehmen | Position | Beginn |
|---|---|---|
| Parallax Clinical Research LLC | Präsident | - |
Ehemalige bekannte Positionen von Stuart Apfel
| Unternehmen | Position | Ende |
|---|---|---|
DOV Pharmaceutical, Inc.
 DOV Pharmaceutical, Inc. Miscellaneous Commercial ServicesCommercial Services DOV Pharmaceutical, Inc. discovers and develops novel drugs. It focuses on the development of novel product candidates for disorders of the central nervous system, or CNS. It have drug development programs that are at the preclinical, Phase I and Phase II clinical stages, including DOV 21,947 (in a Phase II clinical trial for depression), DOV 102,677 (which has completed a Phase I clinical trial) and a preclinical discovery program in reuptake inhibitors and GABA modulators. The company was founded by Arnold S. Lippa in May, 1995 and is headquartered in Somerset, NJ. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2006 |
Purdue Pharma LP
 Purdue Pharma LP Pharmaceuticals: MajorHealth Technology Purdue Pharma LP engages in the development and provision of prescription medicines. It offers a portfolio of medical products in categories, including prescription opioids, sleep, laxatives, antiseptics, and dietary supplement. The company was founded by Raymond R. Sackler in 1991 and is headquartered in Stamford, CT. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2004 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
| Parallax Clinical Research LLC | |
DOV Pharmaceutical, Inc.
DOV Pharmaceutical, Inc. Miscellaneous Commercial ServicesCommercial Services DOV Pharmaceutical, Inc. discovers and develops novel drugs. It focuses on the development of novel product candidates for disorders of the central nervous system, or CNS. It have drug development programs that are at the preclinical, Phase I and Phase II clinical stages, including DOV 21,947 (in a Phase II clinical trial for depression), DOV 102,677 (which has completed a Phase I clinical trial) and a preclinical discovery program in reuptake inhibitors and GABA modulators. The company was founded by Arnold S. Lippa in May, 1995 and is headquartered in Somerset, NJ. | Commercial Services |
Purdue Pharma LP
Purdue Pharma LP Pharmaceuticals: MajorHealth Technology Purdue Pharma LP engages in the development and provision of prescription medicines. It offers a portfolio of medical products in categories, including prescription opioids, sleep, laxatives, antiseptics, and dietary supplement. The company was founded by Raymond R. Sackler in 1991 and is headquartered in Stamford, CT. | Health Technology |
